Richard S. Burns - Concepedia

Concepedia

Author

Richard S. Burns

National Institute of Mental Health

Also Known As

R S Burns, R STANLEY BURNS, R Stanley Burns, R. S. Burns, R. Stanley Burns, R.S. Burns, R.Stanley Burns, Richard Burns, Richard S Burns, Richard S. Burns

72

Publications

5.7K

Citations

30

H-Index

85

Concepts

All Affiliations

National Institute of Mental Health National Institutes of Health National Institute of Neurological Disorders and Stroke Icahn School of Medicine at Mount Sinai Barrow Neurological Institute

RS

About

Richard S. Burns is an author at National Institute of Mental Health specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	4.8K
2	Social Sciences	16	17	4.4K
3	Health Sciences	3	3	112
4	Engineering	2	2	65
5	Management	1	1	48

Richard S. Burns

×

44

Publications

5.7K

Citations

30

H-Index

	Year	Citations
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Richard S. Burns, Chuang C. Chiueh, Sanford P. Markey, Proceedings of the National Academy of Sciences NeurotransmitterNeurotransmissionSocial SciencesNeurologyNeuropathology	1983	2.1K
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism Sanford P. Markey, Jan N. Johannessen, Chuang C. Chiueh, Nature Psychoactive DrugNeurophysiologyMedicineNeurotransmitterNeuropharmacology	1984	779
The Clinical Syndrome of Striatal Dopamine Deficiency Richard S. Burns, Peter A. LeWitt, Michael H. Ebert, New England Journal of Medicine NeuropsychologyNigrostriatal Dopamine NeuronsCorticobasal DegenerationMptp-induced ParkinsonismStriatal Dopamine Deficiency	1985	241
Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat Chuang C. Chiueh, Sanford P. Markey, Richard S. Burns, European Journal of Pharmacology Behavioral NeuroscienceNeurophysiologyNeuroanatomyBehavioral PharmacologyIntranigral Administration	1984	222
IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects Jan N. Johannessen, Chuang C. Chiueh, Richard S. Burns, Life Sciences Parallel DifferencesNeurophysiologyMedicinePhysiologyNeurotoxic Effects	1985	209
Clinical Presentation and Pharmacological Therapy in Corticobasal Degeneration Katie Kompoliti, Christopher G. Goetz, Bradley F. Boeve, Archives of Neurology	1998	195
Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. Chuang C. Chiueh, S. P. Markey, Richard S. Burns, PubMed Behavioral NeuroscienceNeurophysiologyMedicineBehavioral PharmacologyPhysiology	1984	169
The Neurotoxicity of 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the Monkey and Man Richard S. Burns, Sanford P. Markey, Jere Marcus Phillips, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques Cell InjurySocial SciencesToxicological MechanismOxidative StressToxicology	1984	140
Blink rates and disorders of movement Craig N. Karson, Richard S. Burns, Peter A. LeWitt, Neurology NeuropsychologyNormal Control RateMotor ControlSocial SciencesNeurology	1984	137
III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys Chuang C. Chiueh, Richard S. Burns, Sanford P. Markey, Life Sciences Neurodegenerative DiseasesNeurobiology Of DiseasePrimate ModelRhesus MonkeysParkinson Disease	1985	134

Page 1